JO2082B1 - Granules comprising clavulanate and excipients - Google Patents

Granules comprising clavulanate and excipients

Info

Publication number
JO2082B1
JO2082B1 JO19982082A JOP19982082A JO2082B1 JO 2082 B1 JO2082 B1 JO 2082B1 JO 19982082 A JO19982082 A JO 19982082A JO P19982082 A JOP19982082 A JO P19982082A JO 2082 B1 JO2082 B1 JO 2082B1
Authority
JO
Jordan
Prior art keywords
granules
clavulanate
excipients
employing
prepare
Prior art date
Application number
JO19982082A
Other languages
Arabic (ar)
Inventor
ويليام جرويندال جان
Original Assignee
جيست بوكيدس بي. في.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by جيست بوكيدس بي. في. filed Critical جيست بوكيدس بي. في.
Application granted granted Critical
Publication of JO2082B1 publication Critical patent/JO2082B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/424—Oxazoles condensed with heterocyclic ring systems, e.g. clavulanic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Granules of clavulanate containing inert excipients for pharmaceutical formulations have been provided for. Also a process to prepare the same by employing a sieving device preferably using an air jet system has been described.
JO19982082A 1997-11-17 1998-11-17 Granules comprising clavulanate and excipients JO2082B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97203576 1997-11-17

Publications (1)

Publication Number Publication Date
JO2082B1 true JO2082B1 (en) 2000-05-21

Family

ID=8228930

Family Applications (1)

Application Number Title Priority Date Filing Date
JO19982082A JO2082B1 (en) 1997-11-17 1998-11-17 Granules comprising clavulanate and excipients

Country Status (13)

Country Link
EP (1) EP0973520A1 (en)
JP (1) JP2001516365A (en)
CN (1) CN1242705A (en)
AU (1) AU1337999A (en)
BR (1) BR9806280A (en)
CA (1) CA2272402A1 (en)
CO (1) CO4980893A1 (en)
JO (1) JO2082B1 (en)
NO (1) NO993467L (en)
PL (1) PL334517A1 (en)
TR (1) TR199901584T1 (en)
WO (1) WO1999025343A1 (en)
ZA (1) ZA9810499B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AU2001292185A1 (en) 2000-10-12 2002-04-22 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
GB0031267D0 (en) * 2000-12-21 2001-01-31 Smithkline Beecham Plc Novel compositions
AT412344B (en) * 2001-04-12 2005-01-25 Sandoz Ag Pharmaceutical composition useful for reducing rapid degradation of the active ingredient comprises clavulanate, in the form of granulated and hydrophobised particles, and an active ingredient
AT413983B (en) * 2001-04-12 2006-08-15 Sandoz Ag Pharmaceutical composition useful for reducing rapid degradation of the active ingredient comprises clavulanate, in the form of granulated and hydrophobised particles, and an active ingredient
US8293272B2 (en) * 2003-05-02 2012-10-23 Globopharm Pharmazeutische Produktions-Und Handelsgesellschaft M.B.H. Solid pharmaceutical preparation containing levothyroxine and/or liothyronine salts
BRPI0410021A (en) * 2003-05-02 2006-04-25 Globopharm Pharmazeutische Pro solid pharmaceutical preparation containing levothyroxine and / or lyothyronine salts as active substance
FI20080355A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for making tablets containing metformin
FI20080352A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for preparing a tablet with high drug content
FI20080351A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for preparing a tablet with low drug content
US8951562B2 (en) 2006-11-10 2015-02-10 Atacama Labs Oy Method and apparatus or dry granulation
FI20080346A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for making a tablet containing additives
FI20070521L (en) 2006-11-10 2008-05-11 Atacama Labs Oy Granules, tablets and granulation method
FI20080353A0 (en) * 2008-05-09 2008-05-09 Atacama Labs Oy Process for preparing a tablet with extra high drug content
EP2291233B1 (en) 2008-05-09 2019-09-04 Atacama Labs Oy Method for dry granulation
WO2014033077A1 (en) * 2012-08-28 2014-03-06 Dsm Sinochem Pharmaceuticals Netherlands B.V. Composition comprising an antibiotic and a beta-lactamase inhibitor, wherein at| least one of them is in the form of mini-tablets
JP2014062064A (en) * 2012-09-21 2014-04-10 Ohara Yakuhin Kogyo Kk Method of producing tablets containing valsartan
JP6141472B2 (en) * 2016-03-02 2017-06-07 大原薬品工業株式会社 Method for producing valsartan-containing tablets
CN110831582B (en) * 2017-07-05 2023-08-11 诺华股份有限公司 Pharmaceutical composition
CN110051637A (en) * 2019-05-21 2019-07-26 葵花药业集团北京药物研究院有限公司 Amoxicillin and clavulanate potassium preparation and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2251250C3 (en) * 1972-10-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Process for the production of high-dose antibiotic tablets
NZ187013A (en) * 1977-04-27 1985-04-30 Beecham Group Ltd 9-amino-9-deoxy-clavulanic acid derivatives and pharmaceutical compositions
NZ189022A (en) * 1977-12-08 1981-11-19 Beecham Group Ltd Pharmaceutically acceptable particles of clavulanates dispersed in a polymeric binder
EP0281200B1 (en) * 1987-03-02 1994-01-19 Yamanouchi Europe B.V. Pharmaceutical composition, pharmaceutical granulate and process for their preparation
IL109770A0 (en) * 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby

Also Published As

Publication number Publication date
CN1242705A (en) 2000-01-26
JP2001516365A (en) 2001-09-25
NO993467D0 (en) 1999-07-14
ZA9810499B (en) 1999-05-24
CA2272402A1 (en) 1999-05-27
EP0973520A1 (en) 2000-01-26
AU1337999A (en) 1999-06-07
NO993467L (en) 1999-07-14
WO1999025343A1 (en) 1999-05-27
PL334517A1 (en) 2000-02-28
TR199901584T1 (en) 2000-01-21
BR9806280A (en) 2000-02-15
CO4980893A1 (en) 2000-11-27

Similar Documents

Publication Publication Date Title
JO2082B1 (en) Granules comprising clavulanate and excipients
AU3418993A (en) System for delivering an active substance for sustained release
AU5022593A (en) Prodrugs, their preparation and use as pharmaceuticals
AU7572196A (en) Pharmaceutical formulations
AU1218892A (en) Pharmaceutical aerosol formulations
EG23826A (en) Pharmaceutical formulations
AU5087290A (en) Transmembrane formulations for drug administration
MX9704910A (en) Controlled release formulation (albuterol).
AU4341789A (en) Pharmaceutical formulations
AU6397694A (en) Smoke evacuator for smoke generating devices
AU4540396A (en) New stable ganelic formulations containing an acid-labile benzimidazol compound, and production process
AU5337796A (en) Polyaminoacid-based particles for use as active principle vectors, and methods for preparing same
AU4595689A (en) Medicinal aerosol formulations
AU9166591A (en) Method and apparatus for granulation
AU1811592A (en) Hemispherically wide-radiating-angle loudspeaker system
HU9301700D0 (en) Methods for producing biphenylic derivatives and pharmaceutical preparatives containing them as active substance
AU7929391A (en) New 1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles and 1,2,3,4-tetrahydro-beta-carbolines processes for preparing these and pharmaceutical compositions containing them
ZA934037B (en) Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same.
AU1930097A (en) Slow-release pharmaceutical formulations containing mizolastin
MX9709453A (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form.
ZA96392B (en) Pharmaceutical formulations
FI934823A0 (en) FRAMEWORK FOR PHARMACEUTICAL FRAMEWORK, PHARMACEUTICAL ACTIVE BENS (E) INDENDERS
AU3908795A (en) Equine anthelmintic formulations
HK1004200A (en) Aerosol drug formulations
GB9500978D0 (en) Pharmaceutical formulations